-
Microchip Q1 FY2027 net sales $1.485B, up 38% YoY; EPS $0.37 GAAP, $0.76 non-GAAP, above guidance
Net sales $1.485B, up 38% YoY and 13.2% sequentially, above guidance midpoint of $1.456B.
-
Microchip COO Richard Simoncic resigns effective Aug 17 to become CEO of Menlo Microsystems
Richard J. Simoncic, COO, notified resignation on July 23, 2026, effective August 17, 2026.
-
Microchip Q4 net sales $1.311B beat guidance; Non-GAAP EPS $0.57 vs $0.48-$0.52 guide
Revenue of $1.311B up 35.1% YoY and 10.6% sequentially, above $1.260B guidance midpoint.
-
Microchip issues $800M 0% convertible notes due 2030; proceeds to repay commercial paper
Issued $800M 0% convertible senior notes due 2030 (upsized from $600M) with initial conversion price ~$104.17/share, a 40% premium to $74.41 close.
-
Microchip Q3 FY2026 beats: net sales $1.186B, non-GAAP EPS $0.44; guides Q4 net sales $1.26B
GAAP EPS $0.06, non-GAAP EPS $0.44; net sales $1.186B (+15.6% YoY), above guidance of $1.185B.
-
Microchip expects Q3 net sales ~$1,185M, above prior guidance of $1,109-1,149M
Expected net sales about $1,185M for Q3 FY2026 ended Dec 31, 2025, above original guidance of $1,109-1,149M.
-
Microchip Q2 FY2026 rev $1.14B (+6% QoQ); GAAP EPS $0.03, non-GAAP $0.35; guides Q3 ~$1.129B
Net sales $1.140B (up 6% QoQ, down 2% YoY) beat guidance midpoint; GAAP EPS $0.03 vs guided loss; non-GAAP EPS $0.35 in range.
-
Microchip beats Q1 guidance; revenue $1.0755B, non-GAAP EPS $0.27 vs. $0.22-$0.26 range
Net sales $1.0755B, +10.8% sequentially, above revised guidance midpoint of $1.0575B.
-
Microchip Q4 revenue $970.5M beats midpoint; guides June Q $1.02-1.07B
Q4 net sales $970.5M, down 5.4% seq & 26.8% YoY; GAAP loss $0.29/sh; Non-GAAP EPS $0.11 (guidance $0.05-0.15).
-
Microchip issues 27M depositary shares of 7.5% mandatory convertible preferred stock
Issued 27M depositary shares (each 1/20 interest in 7.5% Series A Mand Conv Pref); over-allotment 2.7M exercised in full.
-
Microchip Technology announces restructuring: ~2,000 job cuts, Fab 2 closure accelerated to May 2025
Headcount reduction of approximately 2,000 employees across Fab 4, Fab 5, Philippines, and business units.
-
Microchip Q3 revenue $1.026B, down 41.9% YoY; GAAP net loss $0.10/share
Net sales $1.026B, down 11.8% sequentially and 41.9% from Q3 FY24; slightly above updated guidance of $1.025B.
-
Microchip to close Tempe Fab 2, affecting ~500 employees; expects $90M annual savings
Fab 2 (8-inch wafer facility) shutdown planned by September 2025 quarter; products move to Oregon/Colorado fabs.
-
Microchip CEO Moorthy retires; former CEO Sanghi returns as interim; board reduced to 6
Ganesh Moorthy retired as CEO/President and from the Board effective November 18, 2024.
-
Microchip Q2 FY2025 net sales $1.164B, down 48.4% YoY; EPS $0.14 GAAP, $0.46 non-GAAP
Net sales $1.164B, down 6.2% sequentially and 48.4% YoY; GAAP EPS $0.14, non-GAAP EPS $0.46, both within guidance range.
-
Microchip Technology: unauthorized IT disruption; manufacturing at reduced levels
Detected suspicious IT activity on Aug 17; confirmed unauthorized party disrupted servers and business operations on Aug 19.
-
Microchip Q1 sales down 45.8% YoY; Executive Chair retires as officer; dividend up 10.7%
Net sales $1.241B, down 6.4% sequentially and 45.8% YoY, within guidance midpoint.
-
Microchip issues $1.1B 0.75% convertible notes due 2030; $150M greenshoe exercised
Total offering $1.25B ($1.1B initial + $150M additional notes), net proceeds ~$1.23B after discounts and expenses.
-
Microchip reports Q4 net sales down 40.6% YoY; GAAP EPS $0.28; dividend raised 18%
Q4 net sales $1.326B, down 24.9% sequentially and 40.6% YoY; GAAP EPS $0.28, above guidance midpoint ($0.13-$0.32).
-
Microchip cuts CEO and executive salaries by 20% effective Feb 19, 2024
CEO Ganesh Moorthy and other NEOs (Sanghi, Simoncic, Bjornholt, Drehobl) take 20% salary cut.
-
Microchip Q3 revenue drops 21.7% sequentially; GAAP EPS beats guidance but non-GAAP misses
Net sales $1.766B, down 21.7% QoQ and 18.6% YoY; preliminary guidance had indicated a 22% sequential decline.
-
Microchip warns Q3 revenue down ~22% sequentially, worse than guided 15-20%
Preliminary revenue for Q3 FY2024 (Dec 2023) down ~22% sequentially, vs prior guidance of down 15-20%.
-
Microchip Q2 FY24: GAAP EPS $1.21, Non-GAAP $1.62; rev $2.254B up 8.7% YoY
Net sales $2.254B, down 1.5% seq, up 8.7% YoY; record GAAP net income $666.6M, diluted EPS $1.21 (guidance $1.18-$1.21).
-
Microchip Technology establishes $2.75B commercial paper program
Program allows issuance of unsecured notes up to $2.75B aggregate principal.
-
Microchip posts record Q1 FY2024; GAAP EPS $1.21 beats guidance; dividend raised 36%
Record net sales $2.289B (+16.6% YoY); GAAP EPS $1.21 beats guidance of $1.15-$1.16.
-
Microchip repurchases $90.3M of convertible notes; retires all 2037 notes
Pays $19M to repurchase $5.7M principal of 1.625% 2025 Notes; ~$6.8M remains.
-
Microchip Q4 record sales $2.233B; EPS $1.09/$1.64; dividend +38.8%
Record net sales $2.233B (+21.1% YoY); GAAP EPS $1.09, Non-GAAP EPS $1.64, above guidance midpoints.
-
Microchip settles shareholder derivative suits over Microsemi acquisition for $4M insurer payment and governance reforms
Arizona court preliminarily approved settlement of derivative actions alleging fiduciary breaches related to $10.15B Microsemi acquisition.
-
Microchip posts record Q3 FY2023: net sales $2.169B, GAAP EPS $1.04, debt paydown $719M
Record net sales $2.169B, up 4.6% sequentially and 23.4% YoY; midpoint guidance was $2.156B.
-
Microchip posts record Q2 FY2023 net sales of $2.07B, EPS beat; raises dividend 9%
Record net sales $2.073B (+5.6% QoQ, +25.7% YoY); GAAP EPS $0.98 vs guidance $0.94-0.95.